🔎 Trials Near Me

Akèy › Obèsite › Virginia › Arlington

Etid klinik pou Obèsite nan Arlington, VA

18 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Washington Center For Weight Management And Research /ID# 282047, Arlington
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi lwen
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Washington Cntr Weight Mgmt, Arlington
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Washington Cntr Weight Mgmt, Arlington
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07339423

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
  • Inova Cardiology - Fairfax, Fairfax · 11 mi lwen
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church · 4 mi lwen
  • Carient Heart and Vascular, Manassas · 22 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Manassas Clinical Research Center, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Burke · 11 mi lwen
  • ACCOMPLISH-2 Research Site, Manassas · 22 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Washington Center for Weight Management and Research, Inc, Arlington
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Manassas Clinical Research Center Inc, Manassas · 22 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Arlington
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Conquest Research, Vienna · 9 mi lwen
  • Carient Heart and Vascular, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Brief Inhibitory Training for Eating - Intervention

Ap rekrite
  • George Mason University, Fairfax · 11 mi lwen
Laj 14 a 17 · Tout sèks · Mizajou Jun 17, 2026 · NCT07592728

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Ap rekriteFaz 3Volontè an sante akeyi
  • Vanda Investigational Site, Burke · 11 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Apr 20, 2026 · NCT07446439

Etid Obèsite nan lòt vil

Lòt etid nan Arlington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.